Obsessivecompulsive disorder - PowerPoint PPT Presentation

1 / 66
About This Presentation
Title:

Obsessivecompulsive disorder

Description:

'folie du doute' (madness of doubt) and 'delire du toucher' (delusion of touch) (Flaret, 1869) ... Cross-cultural studies find symptoms are similar in various ... – PowerPoint PPT presentation

Number of Views:45
Avg rating:3.0/5.0
Slides: 67
Provided by: jennife401
Category:

less

Transcript and Presenter's Notes

Title: Obsessivecompulsive disorder


1
Obsessive-compulsive disorder
  • Symptoms
  • Neuropathology
  • Treatments
  • Causes

2
OCD
  • Obsessions persistent thoughts
  • Compulsions persistent behaviors
  • Individual is aware that the behavior or
    obsession is unreasonable or excessive

3
(No Transcript)
4
(No Transcript)
5
Heterogeneity
  • folie du doute (madness of doubt) and delire
    du toucher (delusion of touch) (Flaret, 1869)
  • Checkers vs. washers
  • Continuing challenge

6
OCD
  • ONSET
  • males, childhood, often associated with tic
    disorders
  • Females, puberty and early adulthood
  • 3.3 million adults in the United States (2-3 )
  • Cross-cultural studies find symptoms are similar
    in various racial and ethnic groups

7
Associated Disorders
  • Associated Disorders
  • Trichotillomania
  • Onychophagia
  • Co-morbidity
  • Depression
  • Tourettes
  • body dysmorphic disorder
  • Eating disorders

8
Neuropathology
  • Imaging studies
  • Structural increases or decreases in size of the
    orbitofrontal cortex, striatum, or thalamus
  • Increased activity in caudate, orbitofrontal
    cortex, cingulate cortex
  • Dysfunction of cortical/basal ganglia loop
  • Huntingtons, Tourettes, maybe Parkinsons,
    Sydenhams chorea also exhibit OCD
  • Remember craving and compulsive drug-taking?

9
Structural alterations
10
Reduced left orbitofrontal cortex in OCD patients
correlates with severity of symptoms
Kang, et al., 2004, J Neuropsychiatry Clin
Neurosci
11
Alterations in the anterior cingulate and globus
pallidus
Drug-naïve patients
Szeszko et al., Am J Psychiatry 2004
12
Altered white matter in the anterior cingulate
cortex
13
Altered function of the cortico-striatal-thalamo-c
ortical loop
14
Overactivity of prefrontal-basal ganglia loops
Baxter et al., 1998
15
Increased activity in the thalamus
Saxena et al., Biol Psychiatry, 2001
16
(No Transcript)
17
At rest
  • Increased activity of the orbitofrontal cortex
  • Increased activity of the cingulate cortex
  • Increased activity in the caudate nucleus
  • Increased activity in the thalamus

18
Hyperactivity is exacerbated during symptom
provocation
  • fMRI
  • Contaminated items vs neutral items
  • Handling of contaminated items exacerbated
    activity in the prefrontal cortical areas
    (anterior cingulate, orbitofrontal), the basal
    ganglia, and the amygdala

Breiter et al (1996)
19
Activation in the orbitofrontal cortex and
amygdala during symptom provocation
20
Subtypes of OCD
  • Symmetry/ordering
  • Hoarding
  • Contamination/cleaning
  • Obsessions/checking

21
Mataix-Cols et al., 2004
22
Washing
23
Checking
24
Hoarding
25
There may be distinct neural pathological
patterns associated with different symptom
dimensions
  • Cleaning may be more related to emotional
    processing
  • Checking may be more related to dysfunction in
    attention and inhibitory control

26
Injury-induced OCD
12-year-old female, struck by car Max et al. 1995
Chako et al., 2004
27
Overactivity of cortico-basal ganglia
  • Baseline
  • During provocation of symptoms
  • Specific pattern may depend on OCD type
  • OCD can be caused by damage to the basal ganglia
  • OCD occurs in other prefrontal-basal ganglia
    disorders

28
(No Transcript)
29
(No Transcript)
30
Alterations in other cognitive/emotional processes
31
Activation of the anterior cingulate when errors
are committed on a cognitive task in OCD patients
Ursu et al., Psychol Sci, 2003
32
Cognitive Alterations
  • Memory (working, etc)
  • Set shifting
  • Response inhibition (more errors of commission)

33
Dysfunction of inhibitory processing
34
Altered Direct/Indirect Pathway Balance
  • Overactivity of the DIRECT LOOP

35
Dysfunction of habit formation?
36
Neurochemical alterations
37
Serotonin hypothesis
  • OCD is related to serotonin dysfunction
  • Pharmacological treatments for OCD
  • Clomipramine
  • Fluoxetine (Prozac)
  • Paroxetine (Paxil)
  • Serotonin Antagonists exacerbate symptoms
  • Data on serotonergic measures in OCD patients
    have been conflicting

38
Serotonin modulates the prefrontal cortex,
striatum, and thalamus
39
Symptoms can be exacerbated by increasing 5-HT
function
  • Zohar et al (1987)
  • Double-blind, placebo-controlled, random
    assignment study.
  • Twelve patients and 20 controls were given a
    single dose of 0.5 mg of mcPP, a serotonergic
    agonist that binds 5-HT receptors.
  • Following mCPP, patients with OCD experienced a
    transient but marked excaberation of OCD
    symptoms.
  • No significant change in OCD patients who
    received placebo.
  • Compared with healthy controls, patients
    exhibited greater behavioral changes after mCPP.

40
  • Bell et. al. (2001)
  • Fourteen patients with OCD ingested a tryptophan
    drink to lower the serotonin level in their
    brains.
  • Patients were subjected to stressful situations
    specific to their answers on a survey asking what
    types of situations they typically try to avoid
    in every day life.
  • Compared to the control drink, the tryptophan
    drink led to a significant increase in the
    subjective unit of distress, as well as
    compulsive urges and rituals.
  • The results of this study suggest that Acute
    Tryptophan Depletion may reverse the
    effectiveness of anti-OCD treatments, leading to
    a transient worsening of OCD symptoms, especially
    when patients have to face specific challenging
    situations they would rather avoid.
  • Not always replicated (Barr, 2003)



41
Evidence of 5-HT dysfunction
  • Increased 5-HT2A receptors in caudate which are
    normalized after SSRI treatment (Adams et al.,
    2005, Int J Neuropsychopharmacol)
  • Alterations in serotonin transporters

42
Increased midbrain serotonin transporter binding
sites
Limitations Type of marker used Previous use of
psychotropic drugs Age and sex (menstrual
cycle) Co-morbidity What dysfunction does this
reflect?
Pogarell et al. 2003
43
No difference in serotonin transporter binding
No depression co-morbidity
Simpson et al., Biol Psychiatr. 2003
44
Reduced 5-HT transporters in midbrain
Stengler-Wenzke et al., Eur Arch Psychiatr Clin
Neurosci, 2004
No depression No psychotropic drug use for 6
months
45
Dopamine
  • Up to 40 of OCD patients do not respond to
    SSRIs.
  • Dopamine agonists induce stereotyped movement in
    humans and animals
  • Dopamine agonists can exacerbate OCD symptoms
  • Co-morbidity of Tourettes and OCD (up to 90 of
    individuals with Tourettes have OCD)
  • Adjunctive therapy with conventional
    antipsychotics add to reduction of OCD symptoms
    in individuals treated with SSRIs

46
Increases in striatal dopamine transporter
binding in OCD patients
Kim et al, 2003
47
Increased striatal DA transporters in
psychotropic-naïve OCD patients
Van der Wee, et al., Am J Psychiatry 2004
48
Alterations in striatal D2 receptors
Denys, et al. 2004 Biol Psychaitry
49
Treatments
50
Treatments
  • SSRIs
  • Adjunctive antipsychotics (dopamine antagonists)
  • Behavior therapy
  • Psychosurgery
  • Effective treatment, pharmacologic or behavioral
    therapy, normalizes activity

51
Normalization of striatal activity with SSRI
treatment

Paroxetine

Saxena et al., 2002
52
Normalization of orbitofrontal cortex activation
Saxena et al., 1999
53
Behavioral treatment is effective
Limitations no controls
Nakatani, et al. 2003
54
PET scans of OCD patients
OCD, pre-behavior therapy
OCD, pre-drug treatment
OCD, post-behavior therapy
OCD, post-drug treatment
Behavior- or drug therapy produce similar
reductions in the activity of the basal ganglia
From Baxter, et al., 1992, Arch Gen Psychiat, 49
55
Either drug treatment or behavioral treatment
normalizes brain activity

56
Surgical treatments
  • Destroy connections between the frontal lobe and
    basal ganglia/limbic structures
  • Cingulotomy

57
Psychosurgeries
Cingulotomy
Probes are inserted through the skull
into cingulum.
By leading the tips of probes, the tissue is
burned.
58
(No Transcript)
59
Psychosurgery Success
  • 27 definite improvement, 27 probably
    improvement, 46 no improvement (Baer et al,
    1995)
  • 32 definite improvement, 14 partial
    improvement, 54 no improvement (Dougherty et al,
    2002)

60
Psychosurgeries
Deep Brain Stimulation
1. The surgeon inserts wires through the skull
and into capsule. 2. Wires are permanent and
attached to battery pack implanted in chest. 3.
Battery produces adjustable freq. that has same
effect as the other Surgeries. this has been used
on PD patients.
http//www.erworld.com/sjh_images/OCD.gif
61
Can imaging help predict treatment efficacy?
Overactivation of right caudate predicts
Effectiveness of SSRIS
Overactivation of right orbitofrontal cortex and
bilateral thalamus predicts Effectiveness of
adjunctive neuroleptics
62
Causes
  • Genetics
  • Concordance rates are higher among monozygotic
    twins compared to dizygotic twins
  • First-degree relatives are 3-12 times more likely
    to develop OCD
  • Streptococcal infection immune reaction

63
Genetic targets
  • Polymorphism in the promoter region for the
    serotonergic reuptake transporter
  • 5-HT 1D receptor gene
  • DRD4 receptor mutations

64
PANDAs
  • Pediatric autoimmune neuropsychiatric disorders
    associated with streptococcal infection

65
Case of Frances
Perlmutter et al. 1998
66
Summary
  • OCD is related to dysfunction of prefrontal-basal
    ganglia loops that lead to repetitive thoughts
    and actions
  • Effective treatments normalize this activity
  • Treatments include SSRIs, behavioral therapies
    and psychosurgery
  • Causes include genetic factors and possible
    autoimmune reactions
Write a Comment
User Comments (0)
About PowerShow.com